Ad-hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad-hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world.
Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research
Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
Novartis taps MOOC technology to share chemistry education with the world
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.